"Expert Rev Mol Med"[Jour] - Search Results

Year	Number of Results
1997	2
1998	4
1999	14
2000	9
2001	31
2002	28
2003	30
2004	26
2005	29
2006	32
2007	35
2008	37
2009	38
2010	39
2011	38
2012	19
2013	14
2014	17
2015	21
2016	19
2017	10
2018	6
2019	9
2020	4
2021	21
2022	47
2023	26
2024	13

1

Decoding bioactive signals of the RNA secretome: the cell-free messenger RNA catalogue.

De Sota RE, Quake SR, Sninsky JJ, Toden S. De Sota RE, et al. Expert Rev Mol Med. 2024 Apr 29;26:e12. doi: 10.1017/erm.2024.12. Expert Rev Mol Med. 2024. PMID: 38682644 Review.

2

The multifaceted functions of long non-coding RNA HOTAIR in neuropathologies and its potential as a prognostic marker and therapeutic biotarget.

Ahmad F, Sudesh R, Ahmed AT, Arumugam M, Mathkor DM, Haque S. Ahmad F, et al. Expert Rev Mol Med. 2024 Apr 29;26:e11. doi: 10.1017/erm.2024.11. Expert Rev Mol Med. 2024. PMID: 38682637 Review.

3

Roles of TRP and PIEZO receptors in autoimmune diseases.

Yang B, Ma D, Zhu X, Wu Z, An Q, Zhao J, Gao X, Zhang L. Yang B, et al. Expert Rev Mol Med. 2024 Apr 25;26:e10. doi: 10.1017/erm.2023.23. Expert Rev Mol Med. 2024. PMID: 38659380 Review.

4

Novel radiation and targeted therapy combinations for improving rectal cancer outcomes.

Pennel K, Dutton L, Melissourgou-Syka L, Roxburgh C, Birch J, Edwards J. Pennel K, et al. Expert Rev Mol Med. 2024 Apr 16:1-26. doi: 10.1017/erm.2024.15. Online ahead of print. Expert Rev Mol Med. 2024. PMID: 38623751 Review. No abstract available.

5

The Role of the Cytochrome P450 Superfamily in the Skin.

Chen Q, Wang T, Pan H, Wu X, Yuan H, Mo J, Wei Y, Xiao Y. Chen Q, et al. Expert Rev Mol Med. 2024 Apr 15:1-16. doi: 10.1017/erm.2024.5. Online ahead of print. Expert Rev Mol Med. 2024. PMID: 38621674 Review. No abstract available.

6

AAV-mediated gene therapies for glaucoma and uveitis: are we there yet?

Castro B, Steel JC, Layton CJ. Castro B, et al. Expert Rev Mol Med. 2024 Apr 15;26:e9. doi: 10.1017/erm.2024.4. Expert Rev Mol Med. 2024. PMID: 38618935 Review.

7

Impact of diabetes mellitus on osteoarthritis: a scoping review on biomarkers.

Seow SR, Mat S, Ahmad Azam A, Rajab NF, Safinar Ismail I, Singh DKA, Shahar S, Tan MP, Berenbaum F. Seow SR, et al. Expert Rev Mol Med. 2024 Apr 12;26:e8. doi: 10.1017/erm.2024.7. Expert Rev Mol Med. 2024. PMID: 38606593 Review.

8

Stability-based approaches in chemoproteomics.

George AL, Dueñas ME, Marín-Rubio JL, Trost M. George AL, et al. Expert Rev Mol Med. 2024 Apr 12;26:e6. doi: 10.1017/erm.2024.6. Expert Rev Mol Med. 2024. PMID: 38604802 Review.

9

Trauma diagnostic-related target proteins and their detection techniques.

Wei Y, Ren X, Yuan Z, Hong J, Wang T, Chen W, Xu Y, Ding J, Lin J, Jiang W, Zhang P, Wu Q. Wei Y, et al. Expert Rev Mol Med. 2024 Apr 11;26:e7. doi: 10.1017/erm.2024.3. Expert Rev Mol Med. 2024. PMID: 38602081 Review.

10

Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.

Mongiardi MP, Pallini R, D'Alessandris QG, Levi A, Falchetti ML. Mongiardi MP, et al. Expert Rev Mol Med. 2024 Apr 2;26:e5. doi: 10.1017/erm.2024.8. Expert Rev Mol Med. 2024. PMID: 38563164 Review.

11

DNA methylation in necrotizing enterocolitis.

Frazer LC, Yamaguchi Y, Singh DK, Akopyants NS, Good M. Frazer LC, et al. Expert Rev Mol Med. 2024 Apr 1:1-20. doi: 10.1017/erm.2024.16. Online ahead of print. Expert Rev Mol Med. 2024. PMID: 38557638 Review. No abstract available.

12

The role of deubiquitinases in cardiac disease.

Zhan X, Yang Y, Li Q, He F. Zhan X, et al. Expert Rev Mol Med. 2024 Mar 25;26:e3. doi: 10.1017/erm.2024.2. Expert Rev Mol Med. 2024. PMID: 38525836 Review.

13

Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology.

Elemam NM, Mekky RY, Rashid G, Braoudaki M, Youness RA. Elemam NM, et al. Expert Rev Mol Med. 2024 Jan 8;26:e1. doi: 10.1017/erm.2023.26. Expert Rev Mol Med. 2024. PMID: 38186186 Free PMC article. Review.

14

Strategies and rules for tuning TCR-derived therapy.

Mo G, Lu X, Wu S, Zhu W. Mo G, et al. Expert Rev Mol Med. 2023 Dec 14;26:e4. doi: 10.1017/erm.2023.27. Expert Rev Mol Med. 2023. PMID: 38095091 Review.

15

Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF/ICSI: a systematic review and meta-analysis.

Liu C, Tian T, Lou Y, Li J, Liu P, Li R, Qiao J, Wang Y, Yang R. Liu C, et al. Expert Rev Mol Med. 2023 Dec 14;26:e2. doi: 10.1017/erm.2023.25. Expert Rev Mol Med. 2023. PMID: 38095077 Free PMC article. Review.

16

Molecular mechanisms of action of negative pressure wound therapy: a systematic review.

Ravindhran B, Schafer N, Howitt A, Carradice D, Smith G, Chetter I. Ravindhran B, et al. Expert Rev Mol Med. 2023 Oct 19;25:e29. doi: 10.1017/erm.2023.24. Expert Rev Mol Med. 2023. PMID: 37853784 Review.

17

Evaluation of prostate cancer tissue metabolomics: would clinics utilise it for diagnosis?

Bansal N, Kumar M, Sankhwar SN, Gupta A. Bansal N, et al. Expert Rev Mol Med. 2023 Aug 7;25:e26. doi: 10.1017/erm.2023.22. Expert Rev Mol Med. 2023. PMID: 37548191 Review.

18

A systematic review on antimicrobial activities of green synthesised Selaginella silver nanoparticles.

Wadhwa K, Kaur H, Kapoor N, Ghorai SM, Gupta R, Sahgal A. Wadhwa K, et al. Expert Rev Mol Med. 2023 Aug 3;25:e27. doi: 10.1017/erm.2023.21. Expert Rev Mol Med. 2023. PMID: 37534437 Free PMC article. Review.

19

NF-κB: a mediator that promotes or inhibits angiogenesis in human diseases?

Jiang Y, Zhang J, Shi C, Li X, Jiang Y, Mao R. Jiang Y, et al. Expert Rev Mol Med. 2023 Jul 28;25:e25. doi: 10.1017/erm.2023.20. Expert Rev Mol Med. 2023. PMID: 37503730 Review.

20

microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration.

Wang H. Wang H. Expert Rev Mol Med. 2023 Jul 20;25:e24. doi: 10.1017/erm.2023.19. Expert Rev Mol Med. 2023. PMID: 37469309 Review.

21

Toxicology of pharmaceutical and nutritional longevity compounds.

Kahraman C, Kaya Bilecenoglu D, Sabuncuoglu S, Cankaya IT. Kahraman C, et al. Expert Rev Mol Med. 2023 Jun 22;25:e28. doi: 10.1017/erm.2023.18. Expert Rev Mol Med. 2023. PMID: 37345424 Free PMC article. Review.

22

Inflammasomes in breast cancer: the ignition spark of progression and resistance?

Elgohary S, El Tayebi HM. Elgohary S, et al. Expert Rev Mol Med. 2023 Jun 20;25:e22. doi: 10.1017/erm.2023.14. Expert Rev Mol Med. 2023. PMID: 37337426 Review.

23

Wnt/β-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine.

Wu XL, Lin SG, Mao YW, Wu JX, Hu CD, Lv R, Zeng HD, Zhang MH, Lin LZ, Ouyang SS, Zhao YX. Wu XL, et al. Expert Rev Mol Med. 2023 Jun 19;25:e21. doi: 10.1017/erm.2023.16. Expert Rev Mol Med. 2023. PMID: 37332167 Review.

24

Helicobacter pylori virulence factors: subversion of host immune system and development of various clinical outcomes.

Mohammadzadeh R, Menbari S, Pishdadian A, Farsiani H. Mohammadzadeh R, et al. Expert Rev Mol Med. 2023 Jun 13;25:e23. doi: 10.1017/erm.2023.17. Expert Rev Mol Med. 2023. PMID: 37309681 Review.

25

Dysregulated phosphate metabolism in autism spectrum disorder: associations and insights for future research.

Brown RB. Brown RB. Expert Rev Mol Med. 2023 Jun 13;25:e20. doi: 10.1017/erm.2023.15. Expert Rev Mol Med. 2023. PMID: 37309057 Free PMC article. Review.

26

Dual role of glycans and binding receptors in pathogenesis of enveloped viruses (by mainly focusing on two recent pandemics).

Pourrajab F, Zare-Khormizi MR. Pourrajab F, et al. Expert Rev Mol Med. 2023 May 10;25:e19. doi: 10.1017/erm.2023.12. Expert Rev Mol Med. 2023. PMID: 37161715 Review.

27

New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.

Pirlog BO, Ilut S, Pirlog R, Chiroi P, Nutu A, Radutiu DI, Cuc GD, Berindan-Neagoe I, Nabavi SF, Filosa R, Nabavi SM. Pirlog BO, et al. Expert Rev Mol Med. 2023 May 8;25:e18. doi: 10.1017/erm.2023.10. Expert Rev Mol Med. 2023. PMID: 37154101 Review.

28

Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia.

Parker J, Hockney S, Blaschuk OW, Pal D. Parker J, et al. Expert Rev Mol Med. 2023 May 3;25:e16. doi: 10.1017/erm.2023.13. Expert Rev Mol Med. 2023. PMID: 37132370 Free PMC article. Review.

29

Current updates on arrhythmia within Timothy syndrome: genetics, mechanisms and therapeutics.

Jiang C, Zhang Y. Jiang C, et al. Expert Rev Mol Med. 2023 May 3;25:e17. doi: 10.1017/erm.2023.11. Expert Rev Mol Med. 2023. PMID: 37132248 Free PMC article. Review.

30

25 years of ERMM.

Curtin N. Curtin N. Expert Rev Mol Med. 2023 Apr 18;25:e12. doi: 10.1017/erm.2023.8. Expert Rev Mol Med. 2023. PMID: 37069821 Free PMC article. No abstract available.

31

Fusobacterium nucleatum: a novel immune modulator in breast cancer?

Little A, Tangney M, Tunney MM, Buckley NE. Little A, et al. Expert Rev Mol Med. 2023 Apr 3;25:e15. doi: 10.1017/erm.2023.9. Expert Rev Mol Med. 2023. PMID: 37009688 Free PMC article. Review.

32

Autophagic mechanisms in longevity intervention: role of natural active compounds.

Taban Akça K, Çınar Ayan İ, Çetinkaya S, Miser Salihoğlu E, Süntar İ. Taban Akça K, et al. Expert Rev Mol Med. 2023 Mar 30;25:e13. doi: 10.1017/erm.2023.5. Expert Rev Mol Med. 2023. PMID: 36994671 Free PMC article. Review.

33

MicroRNAs in cancer metastasis: biological and therapeutic implications.

Sell MC, Ramlogan-Steel CA, Steel JC, Dhungel BP. Sell MC, et al. Expert Rev Mol Med. 2023 Mar 17;25:e14. doi: 10.1017/erm.2023.7. Expert Rev Mol Med. 2023. PMID: 36927814 Free PMC article. Review.

34

Telomerase inhibition in malignant gliomas: a systematic review.

D'Alessandris QG, Battistelli M, Pennisi G, Offi M, Martini M, Cenci T, Falchetti ML, Lauretti L, Olivi A, Pallini R, Montano N. D'Alessandris QG, et al. Expert Rev Mol Med. 2023 Mar 15;25:e10. doi: 10.1017/erm.2023.6. Expert Rev Mol Med. 2023. PMID: 36919343 Review.

35

Identity matters: cancer stem cells and tumour plasticity in head and neck squamous cell carcinoma.

Salem A, Salo T. Salem A, et al. Expert Rev Mol Med. 2023 Feb 6;25:e8. doi: 10.1017/erm.2023.4. Expert Rev Mol Med. 2023. PMID: 36740973 Review.

36

Efficacy of immune checkpoint inhibitor monotherapy or combined with other small molecule-targeted agents in ovarian cancer.

Muaibati M, Abuduyilimu A, Zhang T, Dai Y, Li R, Huang F, Li K, Tong Q, Huang X, Zhuang L. Muaibati M, et al. Expert Rev Mol Med. 2023 Jan 24;25:e6. doi: 10.1017/erm.2023.3. Expert Rev Mol Med. 2023. PMID: 36691778 Review.

37

Autophagy of naïve CD4⁺ T cells in aging - the role of body adiposity and physical fitness.

Padilha CS, Kushkestani M, Baptista LP, Krüger K, Lira FS. Padilha CS, et al. Expert Rev Mol Med. 2023 Jan 19;25:e9. doi: 10.1017/erm.2023.2. Expert Rev Mol Med. 2023. PMID: 36655333 Review.

38

Lactate, histone lactylation and cancer hallmarks.

Lv X, Lv Y, Dai X. Lv X, et al. Expert Rev Mol Med. 2023 Jan 9;25:e7. doi: 10.1017/erm.2022.42. Expert Rev Mol Med. 2023. PMID: 36621008 Review.

39

Precision medicine for long QT syndrome: patient-specific iPSCs take the lead.

Yu Y, Deschenes I, Zhao MT. Yu Y, et al. Expert Rev Mol Med. 2023 Jan 4;25:e5. doi: 10.1017/erm.2022.43. Expert Rev Mol Med. 2023. PMID: 36597672 Free PMC article. Review.

40

Modelling Alzheimer's disease using human brain organoids: current progress and challenges.

Yanakiev M, Soper O, Berg DA, Kang E. Yanakiev M, et al. Expert Rev Mol Med. 2022 Dec 15;25:e3. doi: 10.1017/erm.2022.40. Expert Rev Mol Med. 2022. PMID: 36517884 Review.

41

Oral microbiota in cancer: could the bad guy turn good with application of polyphenols?

Antoniraj MG, Devi KP, Berindan-Neagoe I, Nabavi SF, Khayat Kashani HR, Aghaabdollahian S, Afkhami F, Jeandet P, Lorigooini Z, Khayatkashani M, Nabavi SM. Antoniraj MG, et al. Expert Rev Mol Med. 2022 Dec 13;25:e1. doi: 10.1017/erm.2022.39. Expert Rev Mol Med. 2022. PMID: 36511134 Review.

42

Irisin enhances longevity by boosting SIRT1, AMPK, autophagy and telomerase.

Sánchez B, Muñoz-Pinto MF, Cano M. Sánchez B, et al. Expert Rev Mol Med. 2022 Dec 12;25:e4. doi: 10.1017/erm.2022.41. Expert Rev Mol Med. 2022. PMID: 36503597 Free PMC article. Review.

43

Hepatitis B virus DNA methylation and its potential role in chronic hepatitis B.

Low WF, Ngeow YF, Chook JB, Tee KK, Ong SK, Peh SC, Bong JJ, Mohamed R. Low WF, et al. Expert Rev Mol Med. 2022 Nov 16;25:e11. doi: 10.1017/erm.2022.38. Expert Rev Mol Med. 2022. PMID: 36380484 Review.

44

Effects of lifespan-extending interventions on cognitive healthspan.

Culig L, Sahbaz BD, Bohr VA. Culig L, et al. Expert Rev Mol Med. 2022 Nov 15;25:e2. doi: 10.1017/erm.2022.36. Expert Rev Mol Med. 2022. PMID: 36377361 Review.

45

Roles of TGF-β in cancer hallmarks and emerging onco-therapeutic design.

Dai X, Hua D, Lu X. Dai X, et al. Expert Rev Mol Med. 2022 Nov 8;24:e42. doi: 10.1017/erm.2022.37. Expert Rev Mol Med. 2022. PMID: 36345661 Review.

46

Preclinical activities of Cassia tora Linn against aging-related diseases.

Hwang SY, Na CS, Moon BC, Shim JH, Lee MH. Hwang SY, et al. Expert Rev Mol Med. 2022 Oct 25;24:e43. doi: 10.1017/erm.2022.33. Expert Rev Mol Med. 2022. PMID: 36281483 Review.

47

Metabolic signatures of immune cells in chronic kidney disease.

Li J, Yang Y, Wang Y, Li Q, He F. Li J, et al. Expert Rev Mol Med. 2022 Oct 21;24:e40. doi: 10.1017/erm.2022.35. Expert Rev Mol Med. 2022. PMID: 36268748 Free PMC article. Review.

48

Extracellular vesicle isolation, purification and evaluation in cancer diagnosis.

Mortezaee K, Majidpoor J, Fathi F. Mortezaee K, et al. Expert Rev Mol Med. 2022 Oct 21;24:e41. doi: 10.1017/erm.2022.34. Expert Rev Mol Med. 2022. PMID: 36268744

49

Precision oncology using ex vivo technology: a step towards individualised cancer care?

Williams ST, Wells G, Conroy S, Gagg H, Allen R, Rominiyi O, Helleday T, Hullock K, Pennington CEW, Rantala J, Collis SJ, Danson SJ. Williams ST, et al. Expert Rev Mol Med. 2022 Oct 3;24:e39. doi: 10.1017/erm.2022.32. Expert Rev Mol Med. 2022. PMID: 36184897 Free PMC article. Review.

50

The compartmentalised nature of neuronal mitophagy: molecular insights and implications.

Borbolis F, Palikaras K. Borbolis F, et al. Expert Rev Mol Med. 2022 Sep 29;24:e38. doi: 10.1017/erm.2022.31. Expert Rev Mol Med. 2022. PMID: 36172898 Free PMC article. Review.

51

Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives.

Mergia Terefe E, Catalan Opulencia MJ, Rakhshani A, Ansari MJ, Sergeevna SE, Awadh SA, Polatova DS, Abdulkadhim AH, Mustafa YF, Kzar HH, Al-Gazally ME, Kadhim MM, Taherian G. Mergia Terefe E, et al. Expert Rev Mol Med. 2022 Sep 26;24:e37. doi: 10.1017/erm.2022.28. Expert Rev Mol Med. 2022. PMID: 36155126 Review.

52

Regulatory role of JMJD6 in placental development.

Shen X, De Geyter C, Zhang H, Huang G. Shen X, et al. Expert Rev Mol Med. 2022 Sep 19;24:e34. doi: 10.1017/erm.2022.30. Expert Rev Mol Med. 2022. PMID: 36222080 Review.

53

Possibilities of using T-cell biophysical biomarkers of ageing.

González-Bermúdez B, Abarca-Ortega A, González-Sánchez M, De la Fuente M, Plaza GR. González-Bermúdez B, et al. Expert Rev Mol Med. 2022 Sep 16;24:e35. doi: 10.1017/erm.2022.29. Expert Rev Mol Med. 2022. PMID: 36111609 Free PMC article. Review.

54

Glycerol-3-phosphate acyltransferases and metabolic syndrome: recent advances and future perspectives.

Huang Y, Hu K, Lin S, Lin X. Huang Y, et al. Expert Rev Mol Med. 2022 Sep 5;24:e30. doi: 10.1017/erm.2022.23. Expert Rev Mol Med. 2022. PMID: 36059117 Review.

55

Unveil the pain of endometriosis: from the perspective of the nervous system.

Fan P, Li T. Fan P, et al. Expert Rev Mol Med. 2022 Sep 5;24:e36. doi: 10.1017/erm.2022.26. Expert Rev Mol Med. 2022. PMID: 36059111 Review.

56

Mismatch repair is a double-edged sword in the battle against microsatellite instability.

Miller CJ, Usdin K. Miller CJ, et al. Expert Rev Mol Med. 2022 Sep 5;24:e32. doi: 10.1017/erm.2022.16. Expert Rev Mol Med. 2022. PMID: 36059110 Free PMC article. Review.

57

The emerging role of NOTCH3 receptor signalling in human lung diseases.

Bodas M, Subramaniyan B, Karmouty-Quintana H, Vitiello PF, Walters MS. Bodas M, et al. Expert Rev Mol Med. 2022 Sep 2;24:e33. doi: 10.1017/erm.2022.27. Expert Rev Mol Med. 2022. PMID: 36052538 Free PMC article. Review.

58

Erythrocyte oxidative stress and thrombosis.

Bettiol A, Galora S, Argento FR, Fini E, Emmi G, Mattioli I, Bagni G, Fiorillo C, Becatti M. Bettiol A, et al. Expert Rev Mol Med. 2022 Aug 26;24:e31. doi: 10.1017/erm.2022.25. Expert Rev Mol Med. 2022. PMID: 36017709 Free PMC article. Review.

59

Social environment as a modulator of immunosenescence.

Garrido A, Martínez de Toda I, Díaz Del Cerro E, Félix J, Ceprián N, González-Sánchez M, De la Fuente M. Garrido A, et al. Expert Rev Mol Med. 2022 Aug 1;24:e29. doi: 10.1017/erm.2022.24. Expert Rev Mol Med. 2022. PMID: 35912691 Review.

60

Bankoglu EE, Stopper H. Bankoglu EE, et al. Expert Rev Mol Med. 2022 Jul 28;24:e28. doi: 10.1017/erm.2022.22. Expert Rev Mol Med. 2022. PMID: 35899852 Free PMC article. Review.

61

Competing Endogenous RNAs (ceRNAs) in Colorectal Cancer: A Review.

Akhbari MH, Zafari Z, Sheykhhasan M. Akhbari MH, et al. Expert Rev Mol Med. 2022 Jun 24;24:e27. doi: 10.1017/erm.2022.21. Expert Rev Mol Med. 2022. PMID: 35748050 Review.

62

Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review.

Bansal N, Kumar M, Sankhwar SN, Gupta A. Bansal N, et al. Expert Rev Mol Med. 2022 Jun 22;24:e25. doi: 10.1017/erm.2022.20. Expert Rev Mol Med. 2022. PMID: 35730322 Review.

63

The potential role of FNDC5/irisin in various liver diseases: awakening the sleeping beauties.

Wang X, Mao L, Li C, Hui Y, Yu Z, Sun M, Li Y, Guo G, Yang W, Cui B, Fan X, Sun C. Wang X, et al. Expert Rev Mol Med. 2022 Jun 13;24:e23. doi: 10.1017/erm.2022.19. Expert Rev Mol Med. 2022. PMID: 35695040 Review.

64

TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes.

Dai FF, Hu M, Zhang YW, Zhu RH, Chen LP, Li ZD, Huang YJ, Hu W, Cheng YX. Dai FF, et al. Expert Rev Mol Med. 2022 Jun 10;24:e26. doi: 10.1017/erm.2022.18. Expert Rev Mol Med. 2022. PMID: 35687009 Free PMC article. Review.

65

Non-invasive molecular biomarkers for predicting outcomes of micro-TESE in patients with idiopathic non-obstructive azoospermia.

Tang D, Li K, He X, Zhang Y, Cao Y. Tang D, et al. Expert Rev Mol Med. 2022 Jun 6;24:e22. doi: 10.1017/erm.2022.17. Expert Rev Mol Med. 2022. PMID: 35659383 Review.

66

Reduced melatonin levels may facilitate glioblastoma initiation in the subventricular zone.

Ghareghani M, Zibara K, Reiter RJ, Rivest S. Ghareghani M, et al. Expert Rev Mol Med. 2022 May 16;24:e24. doi: 10.1017/erm.2022.15. Expert Rev Mol Med. 2022. PMID: 35570582 Review.

67

Exploring hypoxic biology to improve radiotherapy outcomes.

Li C, Wiseman L, Okoh E, Lind M, Roy R, Beavis AW, Pires IM. Li C, et al. Expert Rev Mol Med. 2022 Apr 27;24:e21. doi: 10.1017/erm.2022.14. Expert Rev Mol Med. 2022. PMID: 35586915 Review.

68

Repositioning anticancer drugs as novel COVID-19 antivirals: targeting structural and functional similarities between viral proteins and cancer.

Low ZY, Yip AJW, Lal SK. Low ZY, et al. Expert Rev Mol Med. 2022 Apr 22;24:1-23. doi: 10.1017/erm.2022.11. Online ahead of print. Expert Rev Mol Med. 2022. PMID: 35450545 Free PMC article. Review.

69

Immunopathogenesis of patients with COVID-19: from the perspective of immune system 'evolution' and 'revolution'.

Lv D, Hu B, Lin X, Wang R, Wu D, Long R, He M, Liao S, Deng D. Lv D, et al. Expert Rev Mol Med. 2022 Apr 12;24:e19. doi: 10.1017/erm.2022.12. Expert Rev Mol Med. 2022. PMID: 35535759 Free PMC article. Review.

70

Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.

Guo S, Chen X, Guo C, Wang W. Guo S, et al. Expert Rev Mol Med. 2022 Apr 11;24:e17. doi: 10.1017/erm.2022.8. Expert Rev Mol Med. 2022. PMID: 35400355 Free PMC article. Review.

71

Systematic review of preterm birth multi-omic biomarker studies.

Gupta JK, Alfirevic A. Gupta JK, et al. Expert Rev Mol Med. 2022 Apr 5;24:1-24. doi: 10.1017/erm.2022.13. Online ahead of print. Expert Rev Mol Med. 2022. PMID: 35379367 Free PMC article. Review.

72

Cancer mutation profiles predict ICIs efficacy in patients with non-small cell lung cancer.

Zhu L, Ye D, Lei T, Wu J, Wang W, Xu B. Zhu L, et al. Expert Rev Mol Med. 2022 Apr 4;24:e16. doi: 10.1017/erm.2022.9. Expert Rev Mol Med. 2022. PMID: 35373730 Review.

73

Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair.

Nikitaki Z, Velalopoulou A, Zanni V, Tremi I, Havaki S, Kokkoris M, Gorgoulis VG, Koumenis C, Georgakilas AG. Nikitaki Z, et al. Expert Rev Mol Med. 2022 Mar 31;24:e15. doi: 10.1017/erm.2022.6. Expert Rev Mol Med. 2022. PMID: 35357290 Review.

74

Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT).

Monti Hughes A. Monti Hughes A. Expert Rev Mol Med. 2022 Mar 31;24:e14. doi: 10.1017/erm.2022.7. Expert Rev Mol Med. 2022. PMID: 35357286 Review.

75

Update on the role of extracellular vesicles in rheumatoid arthritis.

Miao HB, Wang F, Lin S, Chen Z. Miao HB, et al. Expert Rev Mol Med. 2022 Mar 17;24:e12. doi: 10.1017/erm.2021.33. Expert Rev Mol Med. 2022. PMID: 35297366 Free PMC article. Review.

76

COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.

Szekanecz Z, Balog A, Constantin T, Czirják L, Géher P, Kovács L, Kumánovics G, Nagy G, Rákóczi É, Szamosi S, Szűcs G, Vályi-Nagy I. Szekanecz Z, et al. Expert Rev Mol Med. 2022 Mar 15;24:e13. doi: 10.1017/erm.2022.10. Expert Rev Mol Med. 2022. PMID: 35311631 Free PMC article. Review.

77

IL-1β in breast cancer bone metastasis.

Zhou J, Tulotta C, Ottewell PD. Zhou J, et al. Expert Rev Mol Med. 2022 Mar 1;24:e11. doi: 10.1017/erm.2022.4. Expert Rev Mol Med. 2022. PMID: 35227338 Review.

78

In vitro assays for investigating the FLASH effect.

Adrian G, Ruan JL, Paillas S, Cooper CR, Petersson K. Adrian G, et al. Expert Rev Mol Med. 2022 Feb 28;24:e10. doi: 10.1017/erm.2022.5. Expert Rev Mol Med. 2022. PMID: 35225211 Free PMC article. Review.

79

Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications.

Helm A, Fournier C, Durante M. Helm A, et al. Expert Rev Mol Med. 2022 Feb 1;24:e8. doi: 10.1017/erm.2022.2. Expert Rev Mol Med. 2022. PMID: 35101155 Review.

80

Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans.

Naren G, Guo J, Bai Q, Fan N, Nashun B. Naren G, et al. Expert Rev Mol Med. 2022 Jan 31;24:e9. doi: 10.1017/erm.2022.3. Expert Rev Mol Med. 2022. PMID: 35098910 Free PMC article. Review.

81

Single-cell sequencing and its applications in bladder cancer.

Wei W, Rong Y, Sanhe L, Chunxiu Y, Thokerunga E, Cui D, Wang F. Wei W, et al. Expert Rev Mol Med. 2022 Jan 28;24:e6. doi: 10.1017/erm.2021.23. Expert Rev Mol Med. 2022. PMID: 35086606 Review.

82

Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours.

Mao R, Hussein MS, He Y. Mao R, et al. Expert Rev Mol Med. 2022 Jan 28;24:e7. doi: 10.1017/erm.2021.32. Expert Rev Mol Med. 2022. PMID: 35086597 Free PMC article. Review.

83

p38 activation and viral infection.

Wang L, Xia Z, Tang W, Sun Y, Wu Y, Kwok HF, Sun F, Cao Z. Wang L, et al. Expert Rev Mol Med. 2022 Jan 21;24:e4. doi: 10.1017/erm.2021.29. Expert Rev Mol Med. 2022. PMID: 35060846 Review.

84

Decellularised extracellular matrix-based biomaterials for repair and regeneration of central nervous system.

Yaldiz B, Saglam-Metiner P, Yesil-Celiktas O. Yaldiz B, et al. Expert Rev Mol Med. 2022 Jan 7;23:e25. doi: 10.1017/erm.2021.22. Expert Rev Mol Med. 2022. PMID: 34994341 Free PMC article. Review.

85

Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis.

Chan CWH, Li C, Xiao EJ, Li M, Phiri PGM, Yan T, Chan JYW. Chan CWH, et al. Expert Rev Mol Med. 2022 Jan 7;24:e1. doi: 10.1017/erm.2021.28. Expert Rev Mol Med. 2022. PMID: 34991754 Free PMC article. Review.

86

A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.

Yu R, Zhang S, Zhao D, Yuan Z. Yu R, et al. Expert Rev Mol Med. 2022 Jan 6;24:e5. doi: 10.1017/erm.2021.35. Expert Rev Mol Med. 2022. PMID: 34986905 Free PMC article. Review.

87

GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy.

Zuo Y, Chen L, Gu H, He X, Ye Z, Wang Z, Shao Q, Xue C. Zuo Y, et al. Expert Rev Mol Med. 2021 Dec 27;23:e23. doi: 10.1017/erm.2021.27. Expert Rev Mol Med. 2021. PMID: 34955116 Free PMC article. Review.

88

The immunology and immunotherapy for COVID-19.

Liu Y, Zhou X, Liu X, Jiang X. Liu Y, et al. Expert Rev Mol Med. 2021 Dec 17;23:e24. doi: 10.1017/erm.2021.30. Expert Rev Mol Med. 2021. PMID: 34915958 Free PMC article. Review.

89

Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer.

Cao D, Song Q, Li J, Jiang Y, Wang Z, Lu S. Cao D, et al. Expert Rev Mol Med. 2021 Dec 15;23:e21. doi: 10.1017/erm.2021.26. Expert Rev Mol Med. 2021. PMID: 34906271 Review.

90

Biomacromolecule-mediated pulmonary delivery of siRNA and anti-sense oligos: challenges and possible solutions.

Hussain Y, Cui JH, Khan H, Makvandi P, Alam W. Hussain Y, et al. Expert Rev Mol Med. 2021 Dec 15;23:e22. doi: 10.1017/erm.2021.25. Expert Rev Mol Med. 2021. PMID: 34906269 Review.

91

Preclinical models of glioblastoma: limitations of current models and the promise of new developments.

Liu P, Griffiths S, Veljanoski D, Vaughn-Beaucaire P, Speirs V, Brüning-Richardson A. Liu P, et al. Expert Rev Mol Med. 2021 Dec 2;23:e20. doi: 10.1017/erm.2021.20. Expert Rev Mol Med. 2021. PMID: 34852856 Review.

92

Genetic variability of the HPV16 early genes and LCR. Present and future perspectives.

Bletsa G, Zagouri F, Amoutzias GD, Nikolaidis M, Zografos E, Markoulatos P, Tsakogiannis D. Bletsa G, et al. Expert Rev Mol Med. 2021 Dec 1;23:e19. doi: 10.1017/erm.2021.18. Expert Rev Mol Med. 2021. PMID: 34847982 Review.

93

DLX6-AS1: a putative lncRNA candidate in multiple human cancers.

Sheykhhasan M, Ahmadyousefi Y, Seyedebrahimi R, Tanzadehpanah H, Manoochehri H, Dama P, Hosseini NF, Akbari M, Eslami Farsani M. Sheykhhasan M, et al. Expert Rev Mol Med. 2021 Nov 26;23:e17. doi: 10.1017/erm.2021.17. Expert Rev Mol Med. 2021. PMID: 34823630 Review.

94

Alveolar macrophages: novel therapeutic targets for respiratory diseases.

Lim PN, Cervantes MM, Pham LK, Rothchild AC. Lim PN, et al. Expert Rev Mol Med. 2021 Nov 26;23:e18. doi: 10.1017/erm.2021.21. Expert Rev Mol Med. 2021. PMID: 34823627 Review.

95

Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer.

Han L, Wang S, Wei C, Fang Y, Huang S, Yin T, Xiong B, Yang C. Han L, et al. Expert Rev Mol Med. 2021 Nov 11;23:e16. doi: 10.1017/erm.2021.13. Expert Rev Mol Med. 2021. PMID: 34758892 Review.

96

Integrins, cadherins and channels in cartilage mechanotransduction: perspectives for future regeneration strategies.

Dieterle MP, Husari A, Rolauffs B, Steinberg T, Tomakidi P. Dieterle MP, et al. Expert Rev Mol Med. 2021 Oct 27;23:e14. doi: 10.1017/erm.2021.16. Expert Rev Mol Med. 2021. PMID: 34702419 Free PMC article. Review.

97

MicroRNAs regulating SOX2 in cancer progression and therapy response.

Mirzaei S, Saebfar H, Gholami MH, Hashemi F, Zarrabi A, Zabolian A, Entezari M, Hushmandi K, Samarghandian S, Aref AR, Ashrafizadeh M, Khan H. Mirzaei S, et al. Expert Rev Mol Med. 2021 Sep 29;23:e13. doi: 10.1017/erm.2021.15. Expert Rev Mol Med. 2021. PMID: 34583803 Review.

98

The curious case of miR-155 in SLE.

Ibrahim SA, Afify AY, Fawzy IO, El-Ekiaby N, Abdelaziz AI. Ibrahim SA, et al. Expert Rev Mol Med. 2021 Sep 1;23:e11. doi: 10.1017/erm.2021.11. Expert Rev Mol Med. 2021. PMID: 34470679 Review.

99

Dysregulation of immune response in otitis media.

Mather MW, Powell S, Talks B, Ward C, Bingle CD, Haniffa M, Powell J. Mather MW, et al. Expert Rev Mol Med. 2021 Aug 18;23:e10. doi: 10.1017/erm.2021.10. Expert Rev Mol Med. 2021. PMID: 34404500 Free PMC article.

100

Role of metabolomics in identifying cardiac hypertrophy: an overview of the past 20 years of development and future perspective.

Singh SP, Sethi R, Saxena SK, Gupta A. Singh SP, et al. Expert Rev Mol Med. 2021 Aug 11;23:e8. doi: 10.1017/erm.2021.12. Expert Rev Mol Med. 2021. PMID: 34376261 Review.

101

COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes.

Kumar A, Narayan RK, Kulandhasamy M, Prasoon P, Kumari C, Kumar S, Pareek V, Sesham K, Shekhawat PS, Kant K, Kumar S. Kumar A, et al. Expert Rev Mol Med. 2021 Aug 3;23:e7. doi: 10.1017/erm.2021.9. Expert Rev Mol Med. 2021. PMID: 34340720 Free PMC article.

102

Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges.

Reinius MAV, Smyth E. Reinius MAV, et al. Expert Rev Mol Med. 2021 Jun 9;23:e6. doi: 10.1017/erm.2021.3. Expert Rev Mol Med. 2021. PMID: 34103115 Review.

103

Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view.

Hasaart KAL, Bertrums EJM, Manders F, Goemans BF, van Boxtel R. Hasaart KAL, et al. Expert Rev Mol Med. 2021 Apr 27;23:e5. doi: 10.1017/erm.2021.6. Expert Rev Mol Med. 2021. PMID: 33902785 Free PMC article.

104

CXC chemokine ligand 16: a Swiss army knife chemokine in cancer.

Gowhari Shabgah A, Qasim MT, Mojtaba Mostafavi S, Olegovna Zekiy A, Ezzatifar F, Ahmadi M, Mohammadian Haftcheshmeh S, Gholizadeh Navashenaq J. Gowhari Shabgah A, et al. Expert Rev Mol Med. 2021 Apr 21;23:e4. doi: 10.1017/erm.2021.7. Expert Rev Mol Med. 2021. PMID: 33880989 Review.

105

Methylation multiplicity and its clinical values in cancer.

Dai X, Ren T, Zhang Y, Nan N. Dai X, et al. Expert Rev Mol Med. 2021 Mar 31;23:e2. doi: 10.1017/erm.2021.4. Expert Rev Mol Med. 2021. PMID: 33787478 Free PMC article. Review.

106

Biological bases of cancer immunotherapy.

Gonzales Carazas MM, Pinto JA, Casado FL. Gonzales Carazas MM, et al. Expert Rev Mol Med. 2021 Mar 25;23:e3. doi: 10.1017/erm.2021.5. Expert Rev Mol Med. 2021. PMID: 33762030 Free PMC article.

107

Targeting unfolded protein response: a new horizon for disease control.

Khanna M, Agrawal N, Chandra R, Dhawan G. Khanna M, et al. Expert Rev Mol Med. 2021 Mar 4;23:e1. doi: 10.1017/erm.2021.2. Expert Rev Mol Med. 2021. PMID: 33660595 Review.

108

Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities.

Sanz P, Serratosa JM. Sanz P, et al. Expert Rev Mol Med. 2020 Sep 17;22:e4. doi: 10.1017/erm.2020.5. Expert Rev Mol Med. 2020. PMID: 32938505 Free PMC article. Review.

109

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Zhou C, Parsons JL. Zhou C, et al. Expert Rev Mol Med. 2020 Jul 2;22:e3. doi: 10.1017/erm.2020.4. Expert Rev Mol Med. 2020. PMID: 32611474 Free PMC article. Review.

110

DNA damage checkpoint kinases in cancer.

Smith HL, Southgate H, Tweddle DA, Curtin NJ. Smith HL, et al. Expert Rev Mol Med. 2020 Jun 8;22:e2. doi: 10.1017/erm.2020.3. Expert Rev Mol Med. 2020. PMID: 32508294 Review.

111

Pulmonary enteric adenocarcinoma: an overview.

Palmirotta R, Lovero D, D'Oronzo S, Todisco A, Internò V, Mele F, Stucci LS, Silvestris F. Palmirotta R, et al. Expert Rev Mol Med. 2020 Apr 28;22:e1. doi: 10.1017/erm.2020.2. Expert Rev Mol Med. 2020. PMID: 32340641 Review.

112

Essential tremor: genetic update.

Deng H, Wu S, Jankovic J. Deng H, et al. Expert Rev Mol Med. 2019 Dec 10;21:e8. doi: 10.1017/erm.2019.7. Expert Rev Mol Med. 2019. PMID: 31818346 Review.

113

Role of the Wnt signalling pathway in the development of endothelial disorders in response to hyperglycaemia.

Durak-Kozica M, Paszek E, Stępień EŁ. Durak-Kozica M, et al. Expert Rev Mol Med. 2019 Dec 4;21:e7. doi: 10.1017/erm.2019.8. Expert Rev Mol Med. 2019. PMID: 31796147 Review.

114

The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease.

Zhang JQJ, Saravanabavan S, Munt A, Wong ATY, Harris DC, Harris PC, Wang Y, Rangan GK. Zhang JQJ, et al. Expert Rev Mol Med. 2019 Nov 26;21:e6. doi: 10.1017/erm.2019.6. Expert Rev Mol Med. 2019. PMID: 31767049 Review.

115

Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophies.

Hwang J, Yokota T. Hwang J, et al. Expert Rev Mol Med. 2019 Oct 2;21:e5. doi: 10.1017/erm.2019.5. Expert Rev Mol Med. 2019. PMID: 31576784 Review.

116

Warburg and Krebs and related effects in cancer.

Unterlass JE, Curtin NJ. Unterlass JE, et al. Expert Rev Mol Med. 2019 Sep 27;21:e4. doi: 10.1017/erm.2019.4. Expert Rev Mol Med. 2019. PMID: 31558177 Review.

117

Is the conquest of Hepatitis C imminent?

Rivett L, Alexander G. Rivett L, et al. Expert Rev Mol Med. 2019 Mar 26;21:e3. doi: 10.1017/erm.2019.3. Expert Rev Mol Med. 2019. PMID: 30909984 Review.

118

Arbovirus lifecycle in mosquito: acquisition, propagation and transmission.

Wu P, Yu X, Wang P, Cheng G. Wu P, et al. Expert Rev Mol Med. 2019 Mar 13;21:e1. doi: 10.1017/erm.2018.6. Expert Rev Mol Med. 2019. PMID: 30862324 Review.

119

Craniofacial, orofacial and dental disorders: the role of the RAS/ERK pathway.

Vogiatzi A, Mavrothalassitis G. Vogiatzi A, et al. Expert Rev Mol Med. 2019 Mar 13;21:e2. doi: 10.1017/erm.2019.2. Expert Rev Mol Med. 2019. PMID: 30862318 Review.

120

Structure, regulation and related diseases of the actin-binding protein gelsolin.

Feldt J, Schicht M, Garreis F, Welss J, Schneider UW, Paulsen F. Feldt J, et al. Expert Rev Mol Med. 2019 Jan 30;20:e7. doi: 10.1017/erm.2018.7. Expert Rev Mol Med. 2019. PMID: 30698126 Review.

121

Potential clinical applications of circulating cell-free DNA in ovarian cancer patients.

Barbosa A, Peixoto A, Pinto P, Pinheiro M, Teixeira MR. Barbosa A, et al. Expert Rev Mol Med. 2018 Dec 18;20:e6. doi: 10.1017/erm.2018.5. Expert Rev Mol Med. 2018. PMID: 30558693 Review.

122

Animal-type melanoma: dog or wolf? A review of the literature and a case report.

Stucci LS, Palmirotta R, Lovero D, Silvestris E, Cafforio P, Felici C, Todisco A, Nacchiero E, Pezzuto F, Tucci M, Silvestris F. Stucci LS, et al. Expert Rev Mol Med. 2018 Sep 12;20:e5. doi: 10.1017/erm.2018.4. Expert Rev Mol Med. 2018. PMID: 30205850 Review.

123

What has traditional Chinese medicine delivered for modern medicine?

Wang J, Wong YK, Liao F. Wang J, et al. Expert Rev Mol Med. 2018 May 11;20:e4. doi: 10.1017/erm.2018.3. Expert Rev Mol Med. 2018. PMID: 29747718 Review.

124

The genetics and molecular biology of fever-associated seizures or epilepsy.

Deng H, Zheng W, Song Z. Deng H, et al. Expert Rev Mol Med. 2018 Apr 17;20:e3. doi: 10.1017/erm.2018.2. Expert Rev Mol Med. 2018. PMID: 29661262 Review.

125

Oestrogen, progesterone and stem cells: the discordant trio in endometriosis?

Susheelamma CJ, Pillai SM, Asha Nair S. Susheelamma CJ, et al. Expert Rev Mol Med. 2018 Mar 8;20:e2. doi: 10.1017/erm.2017.13. Expert Rev Mol Med. 2018. PMID: 29514724 Review.

126

Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases.

Celec P, Vlková B, Lauková L, Bábíčková J, Boor P. Celec P, et al. Expert Rev Mol Med. 2018 Jan 18;20:e1. doi: 10.1017/erm.2017.12. Expert Rev Mol Med. 2018. PMID: 29343314 Review.

127

Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism.

Garcia-Ortega MB, Lopez GJ, Jimenez G, Garcia-Garcia JA, Conde V, Boulaiz H, Carrillo E, Perán M, Marchal JA, Garcia MA. Garcia-Ortega MB, et al. Expert Rev Mol Med. 2017 Jul 20;19:e9. doi: 10.1017/erm.2017.11. Expert Rev Mol Med. 2017. PMID: 28724458 Review.

128

FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.

Rajan-Babu IS, Lian M, Cheah FSH, Chen M, Tan ASC, Prasath EB, Loh SF, Chong SS. Rajan-Babu IS, et al. Expert Rev Mol Med. 2017 Jul 19;19:e10. doi: 10.1017/erm.2017.10. Expert Rev Mol Med. 2017. PMID: 28720156 Free PMC article. Review.

129

Bilateral Wilms tumour: a review of clinical and molecular features.

Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Charlton J, et al. Expert Rev Mol Med. 2017 Jul 18;19:e8. doi: 10.1017/erm.2017.8. Expert Rev Mol Med. 2017. PMID: 28716159 Free PMC article. Review.

130

Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.

Gil-Bea FJ, Aldanondo G, Lasa-Fernández H, López de Munain A, Vallejo-Illarramendi A. Gil-Bea FJ, et al. Expert Rev Mol Med. 2017 Jun 9;19:e7. doi: 10.1017/erm.2017.9. Expert Rev Mol Med. 2017. PMID: 28597807 Review.

131

Intracellular delivery of biologic therapeutics by bacterial secretion systems.

Walker BJ, Stan GV, Polizzi KM. Walker BJ, et al. Expert Rev Mol Med. 2017 Apr 6;19:e6. doi: 10.1017/erm.2017.7. Expert Rev Mol Med. 2017. PMID: 28382885 Free PMC article. Review.

132

Pandora's Box: mitochondrial defects in ischaemic heart disease and stroke.

Andalib S, Divani AA, Michel TM, Høilund-Carlsen PF, Vafaee MS, Gjedde A. Andalib S, et al. Expert Rev Mol Med. 2017 Apr 5;19:e5. doi: 10.1017/erm.2017.5. Expert Rev Mol Med. 2017. PMID: 28376937 Review.

133

Helicobacter pylori as an oncogenic pathogen, revisited.

Miftahussurur M, Yamaoka Y, Graham DY. Miftahussurur M, et al. Expert Rev Mol Med. 2017 Mar 21;19:e4. doi: 10.1017/erm.2017.4. Expert Rev Mol Med. 2017. PMID: 28322182 Free PMC article. Review.

134

Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.

Garg M. Garg M. Expert Rev Mol Med. 2017 Mar 21;19:e3. doi: 10.1017/erm.2017.6. Expert Rev Mol Med. 2017. PMID: 28322181 Review.

135

FRZB and melusin, overexpressed in LGMD2A, regulate integrin β1D isoform replacement altering myoblast fusion and the integrin-signalling pathway.

Jaka O, Casas-Fraile L, Azpitarte M, Aiastui A, López de Munain A, Sáenz A. Jaka O, et al. Expert Rev Mol Med. 2017 Mar 16;19:e2. doi: 10.1017/erm.2017.3. Expert Rev Mol Med. 2017. PMID: 28300015

136

Molecular approaches for HPV genotyping and HPV-DNA physical status.

Tsakogiannis D, Gartzonika C, Levidiotou-Stefanou S, Markoulatos P. Tsakogiannis D, et al. Expert Rev Mol Med. 2017 Feb 6;19:e1. doi: 10.1017/erm.2017.2. Expert Rev Mol Med. 2017. PMID: 28162121 Review.

137

The complex metabolism of trimethylamine in humans: endogenous and exogenous sources-CORRIGENDUM.

Goel JC, Gaur A, Singhal V, Parakh N, Bhargava B, Sharma A. Goel JC, et al. Expert Rev Mol Med. 2016 Nov 23;18:e19. doi: 10.1017/erm.2016.19. Expert Rev Mol Med. 2016. PMID: 27876109 No abstract available.

138

Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.

Braicu C, Chiorean R, Irimie A, Chira S, Tomuleasa C, Neagoe E, Paradiso A, Achimas-Cadariu P, Lazar V, Berindan-Neagoe I. Braicu C, et al. Expert Rev Mol Med. 2016 Nov 7;18:e18. doi: 10.1017/erm.2016.17. Expert Rev Mol Med. 2016. PMID: 27817751 Review.

139

Emerging therapies for acute intermittent porphyria.

Fontanellas A, Ávila MA, Berraondo P. Fontanellas A, et al. Expert Rev Mol Med. 2016 Nov 2;18:e17. doi: 10.1017/erm.2016.18. Expert Rev Mol Med. 2016. PMID: 27804912 Review.

140

C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication.

Xu Z, Zhang X, Lau J, Yu J. Xu Z, et al. Expert Rev Mol Med. 2016 Sep 27;18:e16. doi: 10.1017/erm.2016.16. Expert Rev Mol Med. 2016. PMID: 27669973

141

Application of multiplex immunoassay technology to investigations of ocular disease.

Jones VS, Wu J, Zhu SW, Huang RP. Jones VS, et al. Expert Rev Mol Med. 2016 Aug 31;18:e15. doi: 10.1017/erm.2016.15. Expert Rev Mol Med. 2016. PMID: 27577534 Review.

142

Molecular mechanism of hepatic steatosis: pathophysiological role of autophagy.

Wang K. Wang K. Expert Rev Mol Med. 2016 Aug 8;18:e14. doi: 10.1017/erm.2016.14. Expert Rev Mol Med. 2016. PMID: 27499351 Review.

143

Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment.

Montoliu-Gaya L, Villegas S. Montoliu-Gaya L, et al. Expert Rev Mol Med. 2016 Jun 30;18:e13. doi: 10.1017/erm.2016.11. Expert Rev Mol Med. 2016. PMID: 27357999 Review.

144

The immunological landscape in necrotising enterocolitis.

Cho SX, Berger PJ, Nold-Petry CA, Nold MF. Cho SX, et al. Expert Rev Mol Med. 2016 Jun 24;18:e12. doi: 10.1017/erm.2016.13. Expert Rev Mol Med. 2016. PMID: 27341512 Free PMC article. Review.

145

Genome research in pre-dementia stages of Alzheimer's disease.

Moreno-Grau S, Ruiz A. Moreno-Grau S, et al. Expert Rev Mol Med. 2016 May 30;18:e11. doi: 10.1017/erm.2016.12. Expert Rev Mol Med. 2016. PMID: 27237222 Review.

146

Editorial.

Sale JE, Cox TM. Sale JE, et al. Expert Rev Mol Med. 2016 May 10;18:e10. doi: 10.1017/erm.2016.10. Expert Rev Mol Med. 2016. PMID: 27160347 No abstract available.

147

Protein pathways working in human follicular fluid: the future for tailored IVF?

Bianchi L, Gagliardi A, Landi C, Focarelli R, De Leo V, Luddi A, Bini L, Piomboni P. Bianchi L, et al. Expert Rev Mol Med. 2016 May 6;18:e9. doi: 10.1017/erm.2016.4. Expert Rev Mol Med. 2016. PMID: 27149979 Free article. Review.

148

The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.

Chhibber-Goel J, Gaur A, Singhal V, Parakh N, Bhargava B, Sharma A. Chhibber-Goel J, et al. Expert Rev Mol Med. 2016 Apr 29;18:e8. doi: 10.1017/erm.2016.6. Expert Rev Mol Med. 2016. PMID: 27126549 Review.

149

Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.

Cuadrado I, Saura M, Castejón B, Martin AM, Herruzo I, Balatsos N, Zamorano JL, Zaragoza C. Cuadrado I, et al. Expert Rev Mol Med. 2016 Apr 8;18:e6. doi: 10.1017/erm.2016.5. Expert Rev Mol Med. 2016. PMID: 27056676 Review.

150

Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.

Toral-Ojeda I, Aldanondo G, Lasa-Elgarresta J, Lasa-Fernández H, Fernández-Torrón R, López de Munain A, Vallejo-Illarramendi A. Toral-Ojeda I, et al. Expert Rev Mol Med. 2016 Apr 8;18:e7. doi: 10.1017/erm.2016.9. Expert Rev Mol Med. 2016. PMID: 27055500 Free PMC article.

151

Mechanisms of prion-induced neurodegeneration.

Saá P, Harris DA, Cervenakova L. Saá P, et al. Expert Rev Mol Med. 2016 Apr 8;18:e5. doi: 10.1017/erm.2016.8. Expert Rev Mol Med. 2016. PMID: 27055367 Review.

152

The microRNA miR-124 suppresses seizure activity and regulates CREB1 activity.

Wang W, Wang X, Chen L, Zhang Y, Xu Z, Liu J, Jiang G, Li J, Zhang X, Wang K, Wang J, Chen G, Luo J. Wang W, et al. Expert Rev Mol Med. 2016 Mar 21;18:e4. doi: 10.1017/erm.2016.3. Expert Rev Mol Med. 2016. PMID: 26996991 Free PMC article. Review.

153

The emerging role of GATA transcription factors in development and disease.

Lentjes MH, Niessen HE, Akiyama Y, de Bruïne AP, Melotte V, van Engeland M. Lentjes MH, et al. Expert Rev Mol Med. 2016 Mar 8;18:e3. doi: 10.1017/erm.2016.2. Expert Rev Mol Med. 2016. PMID: 26953528 Free PMC article. Review.

154

Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis.

Iranpour M, Moghadam AR, Yazdi M, Ande SR, Alizadeh J, Wiechec E, Lindsay R, Drebot M, Coombs KM, Ghavami S. Iranpour M, et al. Expert Rev Mol Med. 2016 Jan 19;18:e1. doi: 10.1017/erm.2015.19. Expert Rev Mol Med. 2016. PMID: 26781343 Free PMC article. Review.

155

Targeting translation: eIF4E as an emerging anticancer drug target.

Lu C, Makala L, Wu D, Cai Y. Lu C, et al. Expert Rev Mol Med. 2016 Jan 18;18:e2. doi: 10.1017/erm.2015.20. Expert Rev Mol Med. 2016. PMID: 26775675 Review.

156

Dental stem cells: a future asset of ocular cell therapy.

Yam GH, Peh GS, Singhal S, Goh BT, Mehta JS. Yam GH, et al. Expert Rev Mol Med. 2015 Nov 10;17:e20. doi: 10.1017/erm.2015.16. Expert Rev Mol Med. 2015. PMID: 26553416 Review.

157

Engineered T cell therapies.

Field AC, Qasim W. Field AC, et al. Expert Rev Mol Med. 2015 Nov 4;17:e19. doi: 10.1017/erm.2015.14. Expert Rev Mol Med. 2015. PMID: 26530808 Review.

158

Advances in the molecular genetics of non-syndromic polydactyly.

Deng H, Tan T, Yuan L. Deng H, et al. Expert Rev Mol Med. 2015 Oct 30;17:e18. doi: 10.1017/erm.2015.18. Expert Rev Mol Med. 2015. PMID: 26515020 Review.

159

Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities.

Chin VT, Nagrial AM, Chou A, Biankin AV, Gill AJ, Timpson P, Pajic M. Chin VT, et al. Expert Rev Mol Med. 2015 Oct 28;17:e17. doi: 10.1017/erm.2015.17. Expert Rev Mol Med. 2015. PMID: 26507949 Free PMC article. Review.

160

Heart valve tissue engineering: how far is the bedside from the bench?

Sanz-Garcia A, Oliver-de-la-Cruz J, Mirabet V, Gandía C, Villagrasa A, Sodupe E, Escobedo-Lucea C. Sanz-Garcia A, et al. Expert Rev Mol Med. 2015 Sep 24;17:e16. doi: 10.1017/erm.2015.15. Expert Rev Mol Med. 2015. PMID: 26399177 Review.

161

Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.

Tao Y, Shi Y, Jia J, Jiang Y, Yang L, Cao Y. Tao Y, et al. Expert Rev Mol Med. 2015 Aug 18;17:e15. doi: 10.1017/erm.2015.13. Expert Rev Mol Med. 2015. PMID: 26282825 Review.

162

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.

Maugeri-Saccà M, Barba M, Pizzuti L, Vici P, Di Lauro L, Dattilo R, Vitale I, Bartucci M, Mottolese M, De Maria R. Maugeri-Saccà M, et al. Expert Rev Mol Med. 2015 Jul 2;17:e14. doi: 10.1017/erm.2015.12. Expert Rev Mol Med. 2015. PMID: 26136233 Review.

163

Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis.

Godler DE, Inaba Y, Schwartz CE, Bui QM, Shi EZ, Li X, Herlihy AS, Skinner C, Hagerman RJ, Francis D, Amor DJ, Metcalfe SA, Hopper JL, Slater HR. Godler DE, et al. Expert Rev Mol Med. 2015 Jul 1;17:e13. doi: 10.1017/erm.2015.11. Expert Rev Mol Med. 2015. PMID: 26132880 Free PMC article. Review.

164

Costamere proteins and their involvement in myopathic processes.

Jaka O, Casas-Fraile L, López de Munain A, Sáenz A. Jaka O, et al. Expert Rev Mol Med. 2015 Jun 19;17:e12. doi: 10.1017/erm.2015.9. Expert Rev Mol Med. 2015. PMID: 26088790 Review.

165

Critical steps in the isolation and expansion of adipose-derived stem cells for translational therapy.

Riis S, Zachar V, Boucher S, Vemuri MC, Pennisi CP, Fink T. Riis S, et al. Expert Rev Mol Med. 2015 Jun 8;17:e11. doi: 10.1017/erm.2015.10. Expert Rev Mol Med. 2015. PMID: 26052798 Review.

166

Current approaches to the diagnosis and treatment of white sponge nevus.

Cai W, Jiang B, Yu F, Yang J, Chen Z, Liu J, Wei R, Zhao S, Wang X, Liu S. Cai W, et al. Expert Rev Mol Med. 2015 May 29;17:e9. doi: 10.1017/erm.2015.7. Expert Rev Mol Med. 2015. PMID: 26021387 Review.

167

Thyroid hormone in the frontier of cell protection, survival and functional recovery.

Videla LA, Fernández V, Cornejo P, Vargas R, Castillo I. Videla LA, et al. Expert Rev Mol Med. 2015 May 25;17:e10. doi: 10.1017/erm.2015.8. Expert Rev Mol Med. 2015. PMID: 26004623 Review.

168

Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.

Kelly MJ, O'Keeffe GW, Sullivan AM. Kelly MJ, et al. Expert Rev Mol Med. 2015 May 13;17:e8. doi: 10.1017/erm.2015.6. Expert Rev Mol Med. 2015. PMID: 25997719 Review.

169

Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.

Rajan-Babu IS, Law HY, Yoon CS, Lee CG, Chong SS. Rajan-Babu IS, et al. Expert Rev Mol Med. 2015 May 4;17:e7. doi: 10.1017/erm.2015.5. Expert Rev Mol Med. 2015. PMID: 25936533 Free PMC article. Review.

170

Hypoxia signalling manipulation for bone regeneration.

Drager J, Harvey EJ, Barralet J. Drager J, et al. Expert Rev Mol Med. 2015 Apr 22;17:e6. doi: 10.1017/erm.2015.4. Expert Rev Mol Med. 2015. PMID: 25900271 Review.

171

Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.

Pandolfi S, Stecca B. Pandolfi S, et al. Expert Rev Mol Med. 2015 Feb 9;17:e5. doi: 10.1017/erm.2015.3. Expert Rev Mol Med. 2015. PMID: 25660620 Free PMC article. Review.

172

Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Lee E, Pandey NB, Popel AS. Lee E, et al. Expert Rev Mol Med. 2015 Jan 30;17:e3. doi: 10.1017/erm.2015.2. Expert Rev Mol Med. 2015. PMID: 25634527 Free PMC article. Review.

173

The noncoding human genome and the future of personalised medicine.

Cowie P, Hay EA, MacKenzie A. Cowie P, et al. Expert Rev Mol Med. 2015 Jan 30;17:e4. doi: 10.1017/erm.2014.23. Expert Rev Mol Med. 2015. PMID: 25634368 Review.

174

Oestrogens as apoptosis regulators in mammalian testis: angels or devils?

Correia S, Cardoso HJ, Cavaco JE, Socorro S. Correia S, et al. Expert Rev Mol Med. 2015 Jan 27;17:e2. doi: 10.1017/erm.2014.25. Expert Rev Mol Med. 2015. PMID: 26258687 Review.

175

Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.

Howl J, Jones S. Howl J, et al. Expert Rev Mol Med. 2015 Jan 27;17:e1. doi: 10.1017/erm.2014.24. Expert Rev Mol Med. 2015. PMID: 26258595 Review.

176

Genetic basis of human left-right asymmetry disorders.

Deng H, Xia H, Deng S. Deng H, et al. Expert Rev Mol Med. 2015 Jan 27;16:e19. doi: 10.1017/erm.2014.22. Expert Rev Mol Med. 2015. PMID: 26258520 Review.

177

The role of endoglin in kidney fibrosis.

Muñoz-Felix JM, Oujo B, Lopez-Novoa JM. Muñoz-Felix JM, et al. Expert Rev Mol Med. 2014 Dec 2;16:e18. doi: 10.1017/erm.2014.20. Expert Rev Mol Med. 2014. PMID: 25439793

178

Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties.

Thorin-Trescases N, Thorin E. Thorin-Trescases N, et al. Expert Rev Mol Med. 2014 Nov 24;16:e17. doi: 10.1017/erm.2014.19. Expert Rev Mol Med. 2014. PMID: 25417860 Review.

179

Dysregulation of calcium homeostasis in muscular dystrophies.

Vallejo-Illarramendi A, Toral-Ojeda I, Aldanondo G, López de Munain A. Vallejo-Illarramendi A, et al. Expert Rev Mol Med. 2014 Oct 8;16:e16. doi: 10.1017/erm.2014.17. Expert Rev Mol Med. 2014. PMID: 25293420 Review.

180

Lymphangiogenesis in renal diseases: passive bystander or active participant?

Yazdani S, Navis G, Hillebrands JL, van Goor H, van den Born J. Yazdani S, et al. Expert Rev Mol Med. 2014 Sep 25;16:e15. doi: 10.1017/erm.2014.18. Expert Rev Mol Med. 2014. PMID: 25252809 Review.

181

Mitochondria-targeted therapies for acute kidney injury.

Tábara LC, Poveda J, Martin-Cleary C, Selgas R, Ortiz A, Sanchez-Niño MD. Tábara LC, et al. Expert Rev Mol Med. 2014 Aug 8;16:e13. doi: 10.1017/erm.2014.14. Expert Rev Mol Med. 2014. PMID: 25104110 Review.

182

Designer functionalised self-assembling peptide nanofibre scaffolds for cartilage tissue engineering.

He B, Yuan X, Zhou A, Zhang H, Jiang D. He B, et al. Expert Rev Mol Med. 2014 Aug 4;16:e12. doi: 10.1017/erm.2014.13. Expert Rev Mol Med. 2014. PMID: 25089851 Review.

183

Copper as a key regulator of cell signalling pathways.

Grubman A, White AR. Grubman A, et al. Expert Rev Mol Med. 2014 May 22;16:e11. doi: 10.1017/erm.2014.11. Expert Rev Mol Med. 2014. PMID: 24849048 Review.

184

Chemical strategies for development of ATR inhibitors.

Llona-Minguez S, Höglund A, Jacques SA, Koolmeister T, Helleday T. Llona-Minguez S, et al. Expert Rev Mol Med. 2014 May 9;16:e10. doi: 10.1017/erm.2014.10. Expert Rev Mol Med. 2014. PMID: 24810715 Review.

185

Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity.

Ruetze M, Richter W. Ruetze M, et al. Expert Rev Mol Med. 2014 May 9;16:e9. doi: 10.1017/erm.2014.9. Expert Rev Mol Med. 2014. PMID: 24810570 Free PMC article. Review.

186

The current landscape of adipose-derived stem cells in clinical applications.

Lim MH, Ong WK, Sugii S. Lim MH, et al. Expert Rev Mol Med. 2014 May 7;16:e8. doi: 10.1017/erm.2014.8. Expert Rev Mol Med. 2014. PMID: 24807467 Review.

187

GLP-1-mediated gene therapy approaches for diabetes treatment.

Tasyurek MH, Altunbas HA, Canatan H, Griffith TS, Sanlioglu S. Tasyurek MH, et al. Expert Rev Mol Med. 2014 Mar 26;16:e7. doi: 10.1017/erm.2014.7. Expert Rev Mol Med. 2014. PMID: 24666581 Review.

188

Biochemical and molecular aspects of spectral diagnosis in calcinosis cutis.

Lin SY. Lin SY. Expert Rev Mol Med. 2014 Mar 11;16:e6. doi: 10.1017/erm.2014.6. Expert Rev Mol Med. 2014. PMID: 24618028 Review.

189

Histo-blood group antigens: a common niche for norovirus and rotavirus.

Tan M, Jiang X. Tan M, et al. Expert Rev Mol Med. 2014 Mar 10;16:e5. doi: 10.1017/erm.2014.2. Expert Rev Mol Med. 2014. PMID: 24606759 Review.

190

Gene-environment interaction in autoimmune disease.

Ellis JA, Kemp AS, Ponsonby AL. Ellis JA, et al. Expert Rev Mol Med. 2014 Mar 7;16:e4. doi: 10.1017/erm.2014.5. Expert Rev Mol Med. 2014. PMID: 24602341 Review.

191

Role of chemokines in proteinuric kidney disorders.

Moreno JA, Moreno S, Rubio-Navarro A, Gómez-Guerrero C, Ortiz A, Egido J. Moreno JA, et al. Expert Rev Mol Med. 2014 Feb 17;16:e3. doi: 10.1017/erm.2014.3. Expert Rev Mol Med. 2014. PMID: 24534600 Review.

192

Influenza reverse genetics: dissecting immunity and pathogenesis.

Ye S, Evans JG, Stambas J. Ye S, et al. Expert Rev Mol Med. 2014 Feb 14;16:e2. doi: 10.1017/erm.2014.4. Expert Rev Mol Med. 2014. PMID: 24528628 Free article. Review.

193

Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.

Wu HH, Lin WC, Tsai KW. Wu HH, et al. Expert Rev Mol Med. 2014 Jan 23;16:e1. doi: 10.1017/erm.2013.16. Expert Rev Mol Med. 2014. PMID: 24456939 Free PMC article. Review.

194

T regulatory cells in childhood arthritis--novel insights.

Pesenacker AM, Wedderburn LR. Pesenacker AM, et al. Expert Rev Mol Med. 2013 Dec 3;15:e13. doi: 10.1017/erm.2013.14. Expert Rev Mol Med. 2013. PMID: 24294966 Review.

195

Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors.

Jurado KA, Engelman A. Jurado KA, et al. Expert Rev Mol Med. 2013 Nov 26;15:e14. doi: 10.1017/erm.2013.15. Expert Rev Mol Med. 2013. PMID: 24274067 Free PMC article. Review.

196

Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.

Koster R, van Vugt MA, Timmer-Bosscha H, Gietema JA, de Jong S. Koster R, et al. Expert Rev Mol Med. 2013 Sep 30;15:e12. doi: 10.1017/erm.2013.13. Expert Rev Mol Med. 2013. PMID: 24074238 Review.

197

Developing translational research infrastructure and capabilities associated with cancer clinical trials.

Hall JA, Brown R. Hall JA, et al. Expert Rev Mol Med. 2013 Sep 27;15:e11. doi: 10.1017/erm.2013.12. Expert Rev Mol Med. 2013. PMID: 24074187 Review.

198

mTOR: more targets of resveratrol?

Widlund AL, Baur JA, Vang O. Widlund AL, et al. Expert Rev Mol Med. 2013 Sep 23;15:e10. doi: 10.1017/erm.2013.11. Expert Rev Mol Med. 2013. PMID: 24060150 Review.

199

Role of toll-like receptors in systemic sclerosis.

Ciechomska M, Cant R, Finnigan J, van Laar JM, O'Reilly S. Ciechomska M, et al. Expert Rev Mol Med. 2013 Aug 28;15:e9. doi: 10.1017/erm.2013.10. Expert Rev Mol Med. 2013. PMID: 23985302 Review.

200

Elastic fibres in health and disease.

Baldwin AK, Simpson A, Steer R, Cain SA, Kielty CM. Baldwin AK, et al. Expert Rev Mol Med. 2013 Aug 20;15:e8. doi: 10.1017/erm.2013.9. Expert Rev Mol Med. 2013. PMID: 23962539 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

618 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

618 results

Results by year